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HIV fusion is mediated by conformational changes in HIV
envelope glycoprotein (Env) that involves assembly of
two heptad repeats (N- and C-HR) in the gp41 ectodo-
main to form a six-helix bundle (6HB). Peptides corre-
sponding to the N- and C-HR of gp41, termed as fusion
inhibitors, are potent inhibitors of HIV infection. How-
ever, HIV rapidly develops resistance to such fusion inhib-
itors. To better understand mechanisms of resistance that
will aid development of new fusion inhibitors, we gener-
ated an escape mutant virus to an N peptide inhibitor
(N44). This virus, however, was also equally resistant to
T20 and other C peptides. This cross-resistance to fusion
inhibitors was surprising because T20 binds the N-HR,
while N44 binds the C-HR. We show that two point muta-
tions, one each in the N-HR and C-HR were responsible
for the resistance, but structural modeling of these muta-
tions indicate that the mutations would not directly
impair peptide binding. Further mechanistic studies of the
resistant Env demonstrated that the mutations conferred
increased infection kinetics, greater sensitivity to sCD4,
enhanced syncytia formation, and enhanced exposure to
CD4-induced epitopes.
In summary these findings indicate a novel resistance
mechanism involving improved receptor usage and faster
entry kinetics. This indirect method of resistance is dis-
tinctively different from previous reports of escape from C
peptide inhibitors that involve reduced peptide-binding
affinity for the endogenous heptad repeat.
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